24 May 2013
Keywords: GENova, patents, cancer drugs
Article | 11 September 2009
US biotechnology firm GENova Biotherapeutics says that it is in the process of acquiring three promising new drug target patents ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 September 2009
10 September 2009
23 May 2013
© 2013 thepharmaletter.com